- Home
- BNTX vs FCNCA Comparison
BNTX vs FCNCA Comparison
Compare BNTX & FCNCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BNTX | FCNCA |
|---|---|---|
| Founded | 2008 | 1898 |
| Country | Germany | United States |
| Employees | N/A | 18141 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.2B | 23.5B |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | BNTX | FCNCA |
|---|---|---|
| Price | $104.54 | $2,039.49 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 10 |
| Target Price | $133.46 | ★ $2,194.60 |
| AVG Volume (30 Days) | ★ 756.5K | 77.0K |
| Earning Date | 05-04-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 0.42% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $3.43 |
| Revenue Next Year | $4.98 | N/A |
| P/E Ratio | ★ N/A | $12.17 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $79.81 | $1,625.08 |
| 52 Week High | $124.00 | $2,232.21 |
Technical Indicators
Market Signals| Indicator | BNTX | FCNCA |
|---|---|---|
| Relative Strength Index (RSI) | 68.13 | 66.79 |
| Support Level | $100.01 | $1,974.84 |
| Resistance Level | $114.06 | $2,196.46 |
| Average True Range (ATR) | 2.64 | 40.84 |
| MACD | 2.12 | 16.21 |
| Stochastic Oscillator | 97.72 | 100.00 |
Price Performance
Historical ComparisonAbout BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
About FCNCA First Citizens BancShares Inc.
First Citizens BancShares Inc. is a Raleigh, N.C.-based financial holding company operating through its subsidiary, First-Citizens Bank & Trust Company. It provides comprehensive retail banking, commercial lending, leasing, and wealth management services via a nationwide branch network and digital platforms. In 2023 acquisition of Silicon Valley Bank, it also specializes in banking for tech, healthcare, and innovation firms.